siRNA Expression Systems for High-Yield Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing siRNA libraries face challenges such as limited yield, stability issues, and off-target effects, which hinder high-throughput screening and the identification of functional genes associated with diseases.
Innovation Solution
A method involving the isolation of RNA from cell populations, conversion into dsDNA fragments, cloning into vectors with promoters and restriction enzyme sites, and transformation into bacterial cells for large-scale siRNA production using a fermenter, ensuring specific siRNA production for target gene silencing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional siRNA production methods are used, then the production process is simple, but the siRNA yield is limited
Solution Approach 1:
The patent combines multiple functions into a single bacterial expression system: RNA transcription, siRNA precursor formation, and p19-mediated stabilization all occur within the same bacterial host. This integration enables high-yield siRNA production while maintaining manageable system complexity through the use of standard molecular biology tools and well-characterized bacterial expression vectors.
2Productivity
If siRNA libraries are produced for high-throughput screening, then functional gene identification is enabled, but off-target effects increase
Solution Approach 1:
The patent creates accurate copies of target gene sequences through reverse transcription of mRNA to cDNA, ensuring that the resulting siRNA libraries precisely match the actual transcriptome. This copying process enables high-throughput screening with minimal off-target effects because each siRNA is derived from authentic cellular RNA sequences rather than predicted or synthetic sequences.
3Measurement precision
If personalized siRNA libraries targeting whole transcriptome are created, then disease-specific gene identification is improved, but production time increases
Solution Approach 1:
The patent performs preliminary actions by isolating and reverse transcribing the entire transcriptome into a comprehensive cDNA library before generating siRNA expression constructs. This upfront preparation of the full transcriptome representation enables rapid generation of personalized siRNA libraries for any disease-specific cell type without time-consuming sequential processing of individual genes.
4Manufacturing precision
If sequence selection is performed for siRNA production, then specificity is improved, but production efficiency decreases
Solution Approach 1:
The patent enables the system to self-select specific siRNA sequences through the natural cellular machinery: the bacterial expression system automatically transcribes the cloned cDNA into siRNA precursors, and the p19 protein automatically binds and stabilizes the correct dsRNA structures. This self-service mechanism eliminates the need for manual sequence selection while maintaining high specificity, as the system inherently produces only those siRNAs corresponding to the inserted cDNA sequences.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables efficient, high-throughput production of siRNAs with minimized off-target effects, allowing for the identification of functional genes and potential therapeutics, particularly suitable for cancer and other diseases, with a significant increase in siRNA yield compared to conventional methods.
Implementation Method 1
This system utilizes the unique function of a p19 polypeptide, which has the ability to bind to and stabilize dsRNA species produced by endogenous RNase III in Escherichia coli
Implementation Method 2
The guide strand bound by RISC then links the complex to RNA by base pairing for degradation such as cleavage of the RNA
Data Source
AI summary
A method of preparing a library of small interfering RNA (siRNA) expression systems for producing siRNA for silencing of target genes by inducing degradation of target gene RNA expression products includes: (i) isolating RNA of one or more target genes from a cell population; (ii) generating RNA fragments from the isolated RNA; (iii) converting the RNA fragments into dsDNA fragments; and (iv) cloning the dsDNA fragments into vectors for forming cloned vectors, each vector including one or more promoters and at least one restriction enzyme site capable of accepting the insertion of at least one dsDNA fragment such that siRNA can be produced. Methods for producing siRNA from the siRNA expression system and methods of identifying a functional target gene for treatment by using the siRNA produced from the siRNA expression system and for identifying RNAi therapeutics are also provided.